Endocrinology, Vol 121, 1375-1382, Copyright © 1987 by Endocrine Society

ARTICLES

Effects of the progesterone antagonist RU486 on ovarian activity in the rat

P van der Schoot, GH Bakker and JG Klijn
Department of Endocrinology, Growth and Reproduction, Faculty of Medicine, Erasmus University, Rotterdam, The Netherlands.

Adult female rats were treated for 2 or 4 weeks with the progesterone antagonist RU486 to study its effect on the regulation of ovarian function. In rats with 5-day ovarian cycles, the vaginal cyclicity disappeared. Uninterrupted vaginal cornification emerged within 4 days after the start of treatment and cornification persisted for the whole period of treatment. It took more than 2 weeks after cessation of 2-4 weeks of treatment before 5-day vaginal cycles reappeared. Ovarian weights increased rapidly resulting from the accumulation of large numbers of corpora lutea. In addition, the ovaries developed occasional follicular cysts which could reach an extremely large size (2 mm or more). Analysis of serial histological sections of ovaries, combined with plasma concentrations of estradiol-17 beta and progesterone, indicated cyclic ovulation and corpus luteum formation together with persistence of functional activity of already existing and newly formed corpora lutea. RU486 seems to have the unique property of dissociating cessation of luteal activity and ovulation in rats. After treatment with RU486, pituitary enlargement and mammary gland alveolar development were observed. It is hypothesized that these effects result from unopposed estrogen action on PRL secretion. The effects of RU486 are reversible: 4 to 5 weeks after the end of treatment ovarian activity seems normal (as evidenced by reduction of ovarian weights and 5-day vaginal cycles) except for the presence of occasional large follicular cysts which may require longer periods for their regression.

This article has been cited by other articles:

				J. N. Lucas, D. G. Rudmann, K. M. Credille, A. R. Irizarry, A. Peter, and P. W. Snyder The Rat Mammary Gland: Morphologic Changes as an Indicator of Systemic Hormonal Perturbations Induced by Xenobiotics Toxicol Pathol, February 1, 2007; 35(2): 199 - 207. [Abstract] [Full Text] [PDF]

				F. Gaytan, C. Bellido, M. Gaytan, C. Morales, and J. E. Sanchez-Criado Differential Effects of RU486 and Indomethacin on Follicle Rupture During the Ovulatory Process in the Rat Biol Reprod, July 1, 2003; 69(1): 99 - 105. [Abstract] [Full Text] [PDF]

				R. Shao, E. Markstrom, P. A. Friberg, M. Johansson, and H. Billig Expression of Progesterone Receptor (PR) A and B Isoforms in Mouse Granulosa Cells: Stage-Dependent PR-Mediated Regulation of Apoptosis and Cell Proliferation Biol Reprod, March 1, 2003; 68(3): 914 - 921. [Abstract] [Full Text] [PDF]

				R. L. Wade, R. A. Van Andel, S. G. Rice, C. L. Banka, and C. A. Dyer Hepatic Lipase Deficiency Attenuates Mouse Ovarian Progesterone Production Leading to Decreased Ovulation and Reduced Litter Size Biol Reprod, April 1, 2002; 66(4): 1076 - 1082. [Abstract] [Full Text] [PDF]

				M. Pall, M. Mikuni, K. Mitsube, and M. Brännström Time-Dependent Ovulation Inhibition of a Selective Progesterone-Receptor Antagonist (Org 31710) and Effects on Ovulatory Mediators in the In Vitro Perfused Rat Ovary Biol Reprod, December 1, 2000; 63(6): 1642 - 1647. [Abstract] [Full Text]

				F. Gaytán, C. Bellido, C. Morales, and J.E. Sánchez-Criado Both Prolactin and Progesterone in Proestrus Are Necessary for the Induction of Apoptosis in the Regressing Corpus Luteum of the Rat Biol Reprod, November 1, 1998; 59(5): 1200 - 1206. [Abstract] [Full Text]

				R. L. Robker, D. L. Russell, L. L. Espey, J. P. Lydon, B. W. O'Malley, and J. S. Richards Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases PNAS, April 25, 2000; 97(9): 4689 - 4694. [Abstract] [Full Text] [PDF]